trending Market Intelligence /marketintelligence/en/news-insights/trending/YeYZfLl8qqUfwwiIqyXL4Q2 content esgSubNav
In This List

Achaogen names CEO

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Achaogen names CEO

Achaogen Inc. appointed president and COO Blake Wise to the position of CEO, effective Jan. 1, 2018.

Wise will also be appointed to the company's board.

Wise succeeds Kenneth Hillan, who is taking on the newly created role of president of research and development. In addition, Hillan will be the president of the company and will remain on the board.